Blood stem cell products: toward sustainable benchmarks for clinical translation.
about
Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Concise review: next-generation cell therapies to prevent infections in neutropenic patients.Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling.Quality cell therapy manufacturing by design.Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
P2860
Blood stem cell products: toward sustainable benchmarks for clinical translation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Blood stem cell products: toward sustainable benchmarks for clinical translation.
@en
type
label
Blood stem cell products: toward sustainable benchmarks for clinical translation.
@en
prefLabel
Blood stem cell products: toward sustainable benchmarks for clinical translation.
@en
P2093
P2860
P356
P1433
P1476
Blood stem cell products: toward sustainable benchmarks for clinical translation.
@en
P2093
Elizabeth Csaszar
Peter W Zandstra
Sandra Cohen
P2860
P304
P356
10.1002/BIES.201200118
P407
P577
2013-01-15T00:00:00Z